Founded by Dr. Hung Tran, MD, MS, CNPR, (in collaboration with other PhDs), Integrated BioSci Investing (“IBI) is a growing community of experts and everyday investors who help one another to invest better. Our approach is based on a new investment philosophy, “Integrated BioSci Investing,” which takes roots in both value/growth that are adapted specifically for bioscience stocks. Our analytical research is powered by the integration of (medical, scientific, and market) expertise to deliver an unprecedented accuracy in clinical trial forecasting that, in and of itself, is one of the requisites to finding alpha bioscience investment. Ultimately, our tireless due diligence and the wisdom of IBI members translate into strong returns for all. To name a couple winners, Nektar Therapeutics, Spectrum Pharmaceuticals, Madrigal Pharmaceuticals, Atara Biotherapeutics, and Crispr Therapeutics, correspondingly delivered +258%, +174%, +180%, +186%, and +173% for our subscribers. As an IBI member, you’ll enjoy the following EXCLUSIVE benefits: daily real-time research articles that are comprehensive and more in-depth than free research articles; access to the chat room with many experts and everyday investors for you to ask your questions live about your favorite stocks (you’re expected to get an answer no later than 24 hours); ability to view our high performing portfolios and their pertinent updates; consulting on strategies to help you setting up your own portfolios; all 5-star stocks (our best ideas) and their updates via a research article or chat; potential to have a research featured on your favorite companies; ability to reach Dr. Tran via phone call or Skype as you wish. Of note, we’ll increase our price soon (SUBSCRIBE to IBI now to lock in the current price and save money). Click the orange FOLLOW button to receive the FREE real-time alerts on our articles and blogs. To read the FREE once-weekly articles covering promising small-cap bioscience firms, check out www.drtranbiosci.com (and make sure to register for our mailing list). You can read up on Dr. Tran’s background in an in-depth article by following this link. http://www.drtranbiosci.com/p/dr-tran.html "Stellar therapeutics for patients. Differentiated intelligence for investors. Premium valuations for firms."